Medtronic Net Change in Cash decreased by 1611.1% to -$136.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 11.7%, from -$154.00M to -$136.00M. Over 3 years (FY 2022 to FY 2025), Net Change in Cash shows an upward trend with a 97.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests the company is accumulating liquidity, while a decrease indicates it spent more on investments, debt repayment, or operations than it generated in cash.
This metric represents the total increase or decrease in a company's cash, cash equivalents, and restricted cash over a...
This is a universal accounting standard used to reconcile the cash flow statement to the balance sheet across all industries and global peers.
cf_net_change_in_cash| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$589.00M | -$104.00M | $579.00M | $235.00M | -$1.57B | $2.69B | -$306.00M | -$2.98B | -$204.00M | -$28.00M | $312.00M | -$339.00M | $27.00M | $83.00M | -$154.00M | $978.00M | -$945.00M | $9.00M | -$136.00M |
| QoQ Change | — | +82.3% | +656.7% | -59.4% | -769.8% | +270.8% | -111.4% | -873.5% | +93.2% | +86.3% | >999% | -208.7% | +108.0% | +207.4% | -285.5% | +735.1% | -196.6% | +101.0% | <-999% |
| YoY Change | — | — | — | — | -167.2% | >999% | -152.8% | <-999% | +87.0% | -101.0% | +202.0% | +88.6% | +113.2% | +396.4% | -149.4% | +388.5% | <-999% | -89.2% | +11.7% |